Sponsor:
AstraZeneca
Code:
NCT07652658
Conditions
Idiopathic Pulmonary Fibrosis (IPF)
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Placebo for AZD8965
AZD8965 low dose
AZD8965 medium dose
AZD8965 high dose
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-04. This information was provided to ClinicalTrials.gov by AstraZeneca on 2026-06-25.